Mulmit

NOVAVAX INCNOVAVAX INC

NVAX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-311,123,479,000452,795,000440,302,0002.58
2024-12-31682,162,000-248,931,000-187,499,000-1.23
2023-12-31983,705,000-566,511,000-545,062,000-5.41
2022-12-311,981,872,000-644,736,000-657,939,000-8.42

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-06-20Rodgers Richard J18,880
2026-06-20Rodgers Richard J18,880
2026-06-20King Rachel K.18,880
2026-06-20King Rachel K.18,880
2026-06-20DOUGLAS RICHARD18,880
2026-06-20DOUGLAS RICHARD18,880
2026-06-20MCGLYNN MARGARET G18,880
2026-06-20MCGLYNN MARGARET G18,880
2026-06-20MOTT DAVID M18,880
2026-06-20MOTT DAVID M18,880
2026-06-20Alton Gregg H18,880
2026-06-20Alton Gregg H18,880

8-K events

FiledItems
2026-08-06Results of operations · Financial statements and exhibits
2026-06-23Submission of matters to a vote
2026-05-06Results of operations · Financial statements and exhibits
2026-02-26Results of operations · Financial statements and exhibits
2026-01-20Entry into a material agreement
2026-01-12Results of operations · Regulation FD disclosure · Financial statements and exhibits
2025-11-06Results of operations · Financial statements and exhibits
2025-11-04Regulation FD disclosure · Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.